Patient Perspective: The Promise of Personalized Medicine

Cancer Misinformation: Its Impact on Patients and Mitigation Strategies

Financial Toxicity of Lung Cancer in the Netherlands

As Treatment Options in Lung Cancer Have Expanded, so Have Costs

Panel Explores Emerging Treatments and Sequencing Strategies for Patients with Advanced NSCLCs Driven by Rare Oncogenes

Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System

Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

In Brief for May 25, 2022

In Brief for June 8, 2022

In Brief for June 22, 2022

Journal of Thoracic Oncology Impact Factor Surpasses 20

Step It Up For Research!